Seattle Children's Hospital

Seattle Children's Hospital

Seattle Children's Hospital functions as the pediatric and adolescent academic medical center for a four-state region. Its investment office manages the endowment that supports the hospital's clinical operations, the Seattle Children's Research Institute, and Seattle Children's Therapeutics. The hospital was founded over a century ago by a group of philanthropic women, and its foundation and guild association remain central fundraising engines. Chief Investment Officer Stan Ra directs a $2.8 billion portfolio (Altss estimate) that underpins the hospital's dual mission of providing care regardless of a family's ability to pay and advancing pediatric research. Real estate holdings include the main campus at 4800 Sand Point Way NE, the Seattle Children's Research Institute's Jack R. MacDonald Building, the Building Cure facility at 1920 Terry Ave, and a Renton office portfolio. The endowment also holds a cryptocurrency donation portfolio. The research division is internationally recognized for work in cancer therapies, genetics, neuroscience, immunology, and infectious disease, conducted in partnership with entities including Fred Hutchinson Cancer Center and the University of Washington School of Medicine. The investment office operates within a broader governance structure that includes board trustees with venture and real estate backgrounds, such as Dan Levitan, co-founder of Maveron, and John Schoettler, former VP of Global Real Estate at Amazon. The hospital is a member of the Children's Hospital Association and the Children's Miracle Network Hospitals. In 2025, U.S. News & World Report again named Seattle Children's among the top 10 best children's hospitals in the U.S. and the best in the Pacific Northwest. Unlike a university endowment, this pool sits inside a non-profit hospital system where investment returns directly offset uncompensated care and fund clinical trials. The governance blend of medical leadership, venture-experienced trustees, and a dedicated CIO creates an in-house asset owner whose capital allocation is yoked tightly to a pediatric research pipeline rather than a generic total-return mandate.